Pharmaceutical News and Articles

AHA: Muvalaplin Reduces Lipoprotein(a) Levels in Individuals With Cardiovascular Risk

Muvalaplin reduces lipoprotein(a) levels, according to a study published online Nov. 20 in the Journal of the American Medical Association to coincide with the

Long-Term Exposure to Wildfire PM2.5 Tied to Higher Odds of Dementia

Long-term exposure to wildfire and nonwildfire fine particulate matter (PM2.5) is associated with increased odds of dementia diagnosis, according to a study pub

FDA Approves Imkeldi (imatinib) Oral Solution for the Treatment of Certain Forms of Leukemia and Other Cancers

Illinois Study Finds Steep Rise in Serious Complications of Pregnancy

MONDAY, Nov. 25, 2024 Chronic health problems like high blood pressure, gestational diabetes and obesity have fueled a troubling rise in maternal health issues

Yoga Helps Women Deal With the Mental Stress of Cancer

A cancer diagnosis can bring overwhelming stress and depression to women, but new research suggests yoga can help ease that emotional toll. A wellness intervent

Vaping Immediately Changes Your Blood Flow

Even when e-cigarettes are nicotine-free, they have an immediate effect on blood vessels, a new imaging study shows. E-cigarettes have long been marketed as a s

Stroke Guidelines Updated, With Focus on Women and GLP-1s

Women, especially those who had high blood pressure during pregnancy or entered menopause before age 45, are among those with a greater risk for stroke. They an

T-Day Dinner, Post-Election: Experts Offer Tips to Keep Things Calm

Politics, especially the 2024 elections, can quickly turn the family Thanksgiving table into a battleground. Steering clear of hot-button topics will not only h

Alpheus Medical Announces Positive Phase 1/2 Trial Results for the Treatment of Recurrent High-Grade Gliomas

CHANHASSEN, Minn., Nov. 24, 2024. Alpheus Medical, Inc., a private, clinical-stage oncology company pioneering sonodynamic therapy (SDT) for the treatment of so

FDA Approves Attruby (acoramidis) to Reduce Cardiovascular Death and Cardiovascular-Related Hospitalization in Patients with ATTR-CM